Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women

Journal of Human Genetics

Volumn 50, Issue 5, 2005, Pages 235-240

  Sudo, Yoshihiro ^a   Ezura, Yoichi ^a,f   Kajita, Mitsuko ^a   Yoshida, Hideyo ^b   Suzuki, Takao ^b   Hosoi, Takayuki ^c   Inoue, Satoshi ^d   Shiraki, Masataka ^e   Ito, Hiromoto ^a   Emi, Mitsuru ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e RESEARCH INSTITUTE AND PRACTICE FOR INVOLUTIONAL DISEASES   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Association study; Bone mineral density; Osteoporosis; Pro opiomelanocortin (POMC); Single nucleotide polymorphism

Indexed keywords

CHOLESTEROL; PROOPIOMELANOCORTIN;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; BODY WEIGHT; BONE DENSITY; BONE MINERAL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BODY MASS INDEX; BODY WEIGHT; BONE DENSITY; CHOLESTEROL; DISEASE SUSCEPTIBILITY; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PRO-OPIOMELANOCORTIN; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 21544472897     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-005-0244-x     Document Type: Article

References (30)

1. Albagha OM, Ralston SH (2003) Genetic determinants of susceptibility to osteoporosis. Endocrinol Metab Clin North Am 32:65-81
2. Appleyard SM, Hayward M, Young JI, Butler AA, Cone RD, Rubinstein M, Low MJ (2003) A role for the endogenous opioid beta-endorphin in energy homeostasis. Endocrinology 144:1753-1760
3. Delplanque J, Barat-Houari M, Dina C, Gallina P, Clement K, Guy-Grand B, Vasseur F, Boutin P, Froguel P (2000) Linkage and association studies between the proopiomelanocortin (POMC) gene and obesity in caucasian families. Diabetologia 43:1554-1557
4. Devote M, Shimoya K, Caminis J, Ott J, Tenenhouse A, Whyte MP, Sereda L, Hall S, Considine E, Williams CJ, Tromp G, Kuivaniemi H, Ala-Kokko L, Proskop DJ, Spotila LD (1998) First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4p. Eur J Hum Genet 6:151-157
5. Ezura Y, Kajita M, Ishida R, Yoshida S, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Orimo H, Emi M (2003) Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women. J Bone Miner Res 19:1296-1301
6. Fujita Y, Ezura Y, Emi M, Sato K, Takada D, Iino Y, Katayama Y, Takahashi K, Kamimura K, Bujo H, Saito Y (2003) Hypercholesterolemia associated with splice-junction variation of inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) gene. J Hum Genet 49:24-28
7. Hattori H, Hirayama T, Nobe Y, Nagano M, Kujiraoka T, Egashira T, Ishii J, Thuji M, Emi M (2002) Eight novel mutations and functional impairments of the LDL receptor. J Hum Genet 47:80-87
8. Hixson JE, Almasy L, Cole S, Birnbaum S, Mitchell BD, Mahaney MC, Stern MP, MacCluer JW, Blangero J, Comuzzie AG (1999) Normal variation in leptin levels is associated with polymorphisms in the proopiomelanocortin gene, POMC. J Clin Endocrinol Metab 84:3187-3191
9. Ishida R, Ezura Y, Emi M, Kajita M, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Ito H, Orimo H (2003) Association of a promoter haplotype (-1542G/-525C) in the tumor necrosis factor receptor associated factor-interacting protein gene with low bone mineral density in Japanese women. Bone 33:237-241
10. Iwasaki H, Emi M, Ezura Y, Ishida R, Suzuki T, Hosoi T, Inoue S, Shiraki M, Swensen J, Orimo H (2003) Association of a Trp16Ser variation in the gonadotropin releasing hormone signal peptide with bone mineral density, revealed by SNP-dependent PCR typing. Bone 32:185-190
11. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137-1141
12. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157
13. Liu YZ, Liu YJ, Robert RR, Deng HW (2003) Molecular studies of identification of genes for osteoporosis: the 2002 update. Endocrinology 177:147-196
14. Livak KJ (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143-149
15. Luger TA, Scholzen TE, Brzoska T, Bohm M (2003) New insights into the functions of alpha-MSH and related peptides in the immune system. Ann NY Acad Sci 994:133-140
16. Manolagas SC (1995) Role of cytokines in bone resorption. Bone 17:63-67
17. Mein CA, Barratt BJ, Dunn MG, Siegmund T, Smith AN, Esposito L, Nutland S, Stevens HE, Wilson AJ, Phillips MS, Jarvis N, Law S, de Arruda M, Todd JA (2000) Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. Genome Res 10:330-343
18. Niu T, Chen C, Cordell H, Yang J, Wang B, Wang Z, Fang Z, Nicholas JS, Clifford JR, Xu X (1999) A genome-wide scan for loci linked to forearm bone mineral density. Hum Genet 104:226-233
19. Patschan D, Loddenkemper K, Buttgereit F (2001) Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 29:498-505
20. Peacock M, Turner CH, Econs MJ, Foroud T (2002) Genetics of osteoporosis. Endocrinol Rev 23:303-326
21. Pritchard LE, Turnbull AV, White A (2002) Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signaling and obesity. J Endocrinol 172:411-421
22. Quandt K, Frech K, Karas H, Wingender E, Werner T (1995) MatInd and Matlnspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23:4878-4884
23. Reid IR (2002) Relationships among body mass, its components, and bone. Bone 31:547-555
24. Riggs BL, Melton LJ III (1986) Involutional osteoporosis. N Engl J Med 314:1676-1686
25. Rodan GA, Martin TJ (2000) Therapeutic approaches to bone diseases. Science 289:1508-1514
26. Santoro N, del Giudice EM, Cirillo G, Raimondo P, Corsi I, Amato A, Grandone A, Perrone L (2004) An insertional polymorphism of the proopiomelanocortin gene is associated with fasting insulin levels in childhood obesity. J Clin Endocrinol Metab 89:4846-4849
27. Schneider S, Roessli D, Excoffier L (2000) Arlequin ver. 2.000: a software for population genetics data analysis. Genetics and Biometry Laboratory, University of Geneva, Geneva, Switzerland
28. Star RA, Rajora N, Huang J, Stock RC, Catania A, Lipton JM (1995) Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 92:8016-8020
29. Weinstein RS, Chen JR, Powers CC (2002) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest 109:1041-1048
30. Weinstein RS, Jia D, Powers CC, Stewart SA, Jilka RL, Parfitt AM, Manolagas SC (2004) The skeletal effects of glucocorticoid excess override those of orchidectomy in mice. Endocrinology 145:1980-1987